PF-03654764 is an orally active, selective histamine H 3 receptor antagonist with K i values of 1.2 nM and 7.9 nM for human H 3 and rat H 3 in whole cell assay, respectively. The combination of PF-03654764 and Fexofenadine ( HY-B0801A ) has the potential for allergic rhinitis research.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Neurological Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Histamine Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.